Mr. Tony Baldassarre of Unidoc reports

UNIDOC HEALTH SIGNS MOU WITH VENTRIPOINT DIAGNOSTICS TO EVALUATE REMOTE CARDIAC ASSESSMENT AND SCREENING PLATFORM

Unidoc Health Corp. has signed a non-exclusive and non-binding memorandum of understanding with Ventripoint Diagnostics Ltd. to evaluate a potential collaboration focused on remote cardiac assessment and cardiovascular screening.

Key take-aways:

• The collaboration will assess Ventripoint's VMS+ platform as an optional cardiac imaging component within selected Unidoc Health Cube configurations and virtual care deployments.
• The proposed hub-and-spoke model would connect community image acquisition with qualified cardiology review, referral and follow-up.
• Initial work will assess pilot sites, workflows, technical requirements and potential deployment partners.

Proposed collaboration

Under the proposed collaboration, Unidoc's configurable H3 Health Cubes, Unidoc Connect software and diagnostic-device integrations would be combined with Ventripoint's VMS+ platform. The parties intend to evaluate a hub-and-spoke model in which community locations support screening and echocardiographic image acquisition, while qualified cardiology hubs provide review, interpretation, referral and follow-up.

VMS+ uses artificial intelligence and proprietary cardiac modelling technology to convert standard 2-D echocardiography images into 3-D cardiac models and quantitative measurements of all four heart chambers. Potential applications may include pulmonary hypertension, heart failure, valvular dysfunction, congenital and childhood onset heart disease, and other cardiovascular conditions for which ventricular function analysis may provide clinical information.

Evaluation program

Potential programs may include remote, rural, indigenous and other underserved communities where clinically appropriate and permitted by applicable requirements. Initial activities are expected to include:

• Identifying potential pilot locations, target populations, clinical purposes and referral pathways;
• Assessing equipment, training, installation, connectivity, interoperability, cybersecurity, privacy and data flow requirements;
• Designing workflows that connect community image acquisition and virtual consultation with qualified cardiology specialists; and
• Evaluating clinical applications and identifying potential health care, government, indigenous, non-governmental, research and financing partners.

Management commentary

"Unidoc's platform is designed exactly for innovative products like Ventripoint's VMS+ -- combining connected devices through our software allows for remote points of service in one care workflow," said Tony Baldassarre, chief executive officer of Unidoc Health. "This MOU provides a framework to assess cardiac imaging as an added capability and determine how community-based assessment can be linked with specialist review."

"Access to accurate and timely cardiac information can be challenging in remote and underserved communities," said Hugh MacNaught, president and chief executive officer of Ventripoint. "The proposed collaboration will evaluate how VMS+ and Unidoc's connected-care platform could link community assessment with qualified cardiology expertise."

Building on Unidoc's growth

Unidoc Connect, the company's enterprise e-health platform, recorded approximately 260,000 visits from March through September, 2025, and surpassed one million recorded visits by April, 2026. The increase comes from both new customers and expanded use by customers that transitioned to Unidoc through the March, 2025, purchase of Agnes Connect software and related AMD telemedicine assets. The MOU supports Unidoc's strategy of adding clinical capabilities to its connected care platform.

Next steps

Any pilot or commercial deployment would require a separate written project plan or definitive agreement addressing clinical governance, regulatory requirements, informed consent, privacy, cybersecurity, data residency, training, quality assurance, patient follow-up, costs, commercial terms and implementation responsibilities.

The memorandum of understanding is non-exclusive and principally non-binding, except for customary provisions. Neither party is obligated to purchase, sell, license, integrate or deploy any product or service. There can be no assurance that the parties will enter into a definitive agreement or that any pilot or commercial program will proceed.

About Unidoc Health Corp.

Unidoc is developing e-health solutions intended to support virtual clinical consultations through remote health care points of service. The company combines software, diagnostic devices and communications tools so patients can access consultations from locations outside of a physician's office. Unidoc's focus is physical access: helping governments, institutions and organizations deploy remote clinical access points for populations challenged by distance, access, technology use or care availability.

Unidoc is focused on building shareholder value through product deployment, commercialization and partnerships.

About Ventripoint Diagnostics Ltd.

Ventripoint develops artificial-intelligence-enabled cardiac imaging software for echocardiography. Its VMS+ platform uses proprietary knowledge-based reconstruction technology to generate 3-D models and quantitative measurements of all four chambers of the heart from standard 2-D ultrasound images.

VMS+ is designed for use with ultrasound systems from major vendors and for deployment across hospital, community and remote care settings.

We seek Safe Harbor.